• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环丙沙星抑制激素抵抗性前列腺癌细胞的生长,并增强依托泊苷的作用效果。

Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells.

作者信息

El-Rayes Basil F, Grignon Robert, Aslam Naveed, Aranha Olivia, Sarkar Fazlul H

机构信息

Department of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.

出版信息

Int J Oncol. 2002 Jul;21(1):207-11.

PMID:12063570
Abstract

Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer related deaths in men in the United States. Ciprofloxacin is a relatively non-toxic antibiotic that can be easily administered orally with large volume of distribution and good tissue penetration. Studies from others and our laboratory have recently reported its anti-tumor activity in a variety of human tumor cells. In our current experiment, we studied the effect of ciprofloxacin on a hormone resistant prostate cancer (HRPC) cell line, PC-3. Our study shows significant in vitro cell growth inhibition of PC-3 cell line (p=0.0001) and also shows that there is a synergistic increase in the antiproliferative effect of etoposide when these cells are pretreated with ciprofloxacin for 24 h, prior to etoposide exposure (p=0.0001). Western blot analysis of the protein extracts from these cells showed down-regulation of Bcl-2, altering the ratio of Bax:Bcl-2 favoring apoptosis. In our study no significant effect was seen on p21WAF1 expression by the combination of ciprofloxacin and etoposide but there was down-regulation of p21WAF1 gene by ciprofloxacin alone. Ciprofloxacin also inhibited NF-kappaB binding to DNA. Further studies in this area are warranted as the roles of p21WAF1, Bax/Bcl-2 and NF-kappaB may be important molecular events in mediating the antiproliferative and apoptosis inducing effect of etoposide in combination with ciprofloxacin in HRPC cells.

摘要

前列腺癌是美国男性中最常被诊断出的癌症,也是癌症相关死亡的第二大主要原因。环丙沙星是一种相对无毒的抗生素,易于口服,分布容积大,组织穿透力强。其他研究机构和我们实验室的研究最近报道了其在多种人类肿瘤细胞中的抗肿瘤活性。在我们当前的实验中,我们研究了环丙沙星对激素抵抗性前列腺癌(HRPC)细胞系PC-3的影响。我们的研究表明,PC-3细胞系在体外有显著的细胞生长抑制作用(p = 0.0001),并且还表明,在暴露于依托泊苷之前,先用环丙沙星预处理这些细胞24小时,依托泊苷的抗增殖作用会协同增强(p = 0.0001)。对这些细胞的蛋白质提取物进行的蛋白质印迹分析显示,Bcl-2表达下调,改变了Bax:Bcl-2的比例,有利于细胞凋亡。在我们的研究中,环丙沙星和依托泊苷联合使用对p21WAF1表达没有显著影响,但单独使用环丙沙星会使p21WAF1基因下调。环丙沙星还抑制NF-κB与DNA的结合。由于p21WAF1、Bax/Bcl-2和NF-κB的作用可能是介导依托泊苷与环丙沙星联合使用对HRPC细胞的抗增殖和诱导凋亡作用的重要分子事件,因此有必要在这一领域进行进一步研究。

相似文献

1
Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells.环丙沙星抑制激素抵抗性前列腺癌细胞的生长,并增强依托泊苷的作用效果。
Int J Oncol. 2002 Jul;21(1):207-11.
2
Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.环丙沙星对人前列腺癌细胞生长的抑制作用与细胞周期阻滞和细胞凋亡有关。
Int J Oncol. 2003 Apr;22(4):787-94.
3
Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.吲哚 - 3 - 甲醇(I3C)可诱导前列腺癌细胞的细胞生长抑制、G1期细胞周期阻滞及凋亡。
Oncogene. 2001 May 24;20(23):2927-36. doi: 10.1038/sj.onc.1204365.
4
Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.环丙沙星介导人膀胱移行细胞癌细胞系的细胞生长抑制、S/G2-M期细胞周期阻滞及凋亡。
Clin Cancer Res. 2000 Mar;6(3):891-900.
5
Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.灵芝抑制人前列腺癌细胞PC-3的增殖并诱导其凋亡。
Int J Oncol. 2004 May;24(5):1093-9.
6
Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1.造血生长因子对原发性人类急性髓系白血病的细胞保护作用并非通过BCL-2、bax或p21WAF1/CIP1的变化介导。
In Vivo. 1999 Jan-Feb;13(1):1-6.
7
Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells.核因子-κB、Bax和Bcl-2在芹菜素诱导人前列腺癌细胞细胞周期阻滞和凋亡中的作用
Oncogene. 2002 May 23;21(23):3727-38. doi: 10.1038/sj.onc.1205474.
8
Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.反义蛋白激酶A RIα与羟基喜树碱协同作用,抑制人癌细胞生长并诱导其凋亡:联合治疗的分子基础
Clin Cancer Res. 2003 Mar;9(3):1171-8.
9
Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line.金雀异黄素诱导头颈部鳞状细胞癌细胞系发生分子变化。
Int J Oncol. 2000 Feb;16(2):333-8.
10
Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.Id-1表达通过激活前列腺癌细胞中的NF-κB信号通路促进细胞存活。
Oncogene. 2003 Jul 17;22(29):4498-508. doi: 10.1038/sj.onc.1206693.

引用本文的文献

1
Intratumoral microbiota: implications for cancer progression and treatment.肿瘤内微生物群:对癌症进展和治疗的影响。
Front Microbiol. 2025 Jul 28;16:1551515. doi: 10.3389/fmicb.2025.1551515. eCollection 2025.
2
Repurposing fluoroquinolones as cancer chemosensitizers: a way to overcome cancer therapeutic bottleneck.将氟喹诺酮类药物重新用作癌症化疗增敏剂:一种克服癌症治疗瓶颈的方法。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 11. doi: 10.1007/s00210-025-04508-x.
3
Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations.
基于牛磺酸的杂合药物作为潜在的抗癌治疗剂:体外、体内评估
Pharmaceuticals (Basel). 2025 Jul 18;18(7):1056. doi: 10.3390/ph18071056.
4
Suppressive effect of topical moxifloxacin on imiquimod-induced model of psoriasis in mice.局部用莫西沙星对咪喹莫特诱导的小鼠银屑病模型的抑制作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 3. doi: 10.1007/s00210-025-04317-2.
5
From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents.从感染到肿瘤:探索环丙沙星衍生物作为抗癌药物的治疗潜力
Pharmaceuticals (Basel). 2025 Jan 9;18(1):72. doi: 10.3390/ph18010072.
6
Synergistic Potential of Antibiotics with Cancer Treatments.抗生素与癌症治疗的协同潜力。
Cancers (Basel). 2024 Dec 28;17(1):59. doi: 10.3390/cancers17010059.
7
Drug repurposing of fluoroquinolones as anticancer agents in 2023.2023年氟喹诺酮类药物作为抗癌剂的药物重新利用。
RSC Adv. 2024 Nov 20;14(50):37114-37130. doi: 10.1039/d4ra03571b. eCollection 2024 Nov 19.
8
Immunomodulatory Effects of Fluoroquinolones in Community-Acquired Pneumonia-Associated Acute Respiratory Distress Syndrome.氟喹诺酮类药物在社区获得性肺炎相关急性呼吸窘迫综合征中的免疫调节作用
Biomedicines. 2024 Mar 29;12(4):761. doi: 10.3390/biomedicines12040761.
9
N-Acylated Ciprofloxacin Derivatives: Synthesis and In Vitro Biological Evaluation as Antibacterial and Anticancer Agents.N-酰化环丙沙星衍生物:作为抗菌和抗癌药物的合成及体外生物学评价
ACS Omega. 2023 May 18;8(21):18663-18684. doi: 10.1021/acsomega.3c00554. eCollection 2023 May 30.
10
Novel ciprofloxacin and norfloxacin-tetrazole hybrids as potential antibacterial and antiviral agents: Targeting topoisomerase and SARS-CoV-2-MPro.新型环丙沙星和诺氟沙星-四氮唑杂化物作为潜在的抗菌和抗病毒药物:靶向拓扑异构酶和SARS-CoV-2-MPro
J Mol Struct. 2023 Feb 15;1274:134507. doi: 10.1016/j.molstruc.2022.134507. Epub 2022 Nov 7.